Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model

類似資料

• Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor
  著者:: Ambrose, Paul G., 等
  出版事項: (2017)
• Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model
  著者:: VanScoy, Brian D., 等
  出版事項: (2016)
• Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model
  著者:: VanScoy, Brian D., 等
  出版事項: (2020)
• Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model
  著者:: VanScoy, Brian, 等
  出版事項: (2013)
• Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
  著者:: VanScoy, Brian D., 等
  出版事項: (2015)